Jim Simons Roivant Sciences Ltd. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$9.87 - $11.8 $9.95 Million - $11.9 Million
1,008,600 New
1,008,600 $10.6 Million
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $72,981 - $692,604
143,100 Added 169.75%
227,400 $732,000
Q2 2022

Aug 12, 2022
BUY
$2.81 - $4.84 $236,883 - $408,012
84,300 New
84,300 $343,000
Q1 2022

May 13, 2022
SELL
$4.74 - $9.91 $157,368 - $329,012
-33,200 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$5.86 - $13.52 $194,552 - $448,864
33,200 New
33,200 $335,000

Others Institutions Holding ROIV

# of Institutions
308
Shares Held
496M
Call Options Held
989K
Put Options Held
1.15M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email